Literature DB >> 27128587

Editorial: The ARUBA study: where do we go from here?

Mohamed Samy Elhammady1, Roberto C Heros1.   

Abstract

Mesh：

Year:  2016        PMID： 27128587     DOI： 10.3171/2015.7.JNS151408

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  6 in total

1.  What neurointerventionists think about the treatment of unruptured brain arteriovenous malformations: the complexity of moving towards evidence-based treatment.

Authors:  Mayank Goyal; Johanna M Ospel; Nima Kashani; Adnan H Siddiqui; Ricardo Hanel; Mohammed Almekhlafi; René Chapot
Journal:  Neuroradiology       Date:  2020-04       Impact factor: 2.804

2.  Predictive Value of MRI in Diagnosing Brain AVM Recurrence after Angiographically Documented Exclusion in Children.

Authors:  A Jhaveri; A Amirabadi; P Dirks; A V Kulkarni; M M Shroff; N Shkumat; T Krings; V M Pereira; V Rea; P Muthusami
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-27       Impact factor: 3.825

3.  Multimodality Management in bAVM Surgery - Recent Experience from International Cerebrovascular Fellowship.

Authors:  Adi Ahmetspahic; Eldin Burazerovic; Edin Hajdarpasic; Almir Dzurlic; Ibrahim Omerhodzic; Haso Sefo; Yoko Kato
Journal:  Med Arch       Date:  2021-06

Review 4.  Curative Embolization of Small Brain Arteriovenous Malformations by Ethyl Vinyl Alcohol Copolymer: A Systematic Review and Meta-Analysis.

Authors:  Sharad Ghatge; Pratik Itti
Journal:  Cureus       Date:  2022-07-25

Review 5.  Updates in arteriovenous malformation management: the post-ARUBA era.

Authors:  James Feghali; Judy Huang
Journal:  Stroke Vasc Neurol       Date:  2019-09-21

6.  Practicing outcome-based medical care using pragmatic care trials.

Authors:  Tim E Darsaut; Jean Raymond
Journal:  Trials       Date:  2020-10-29       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.